NCT06378645

Brief Summary

Penile erection is an unwanted event in transurethral (through the urethra) surgeries, which may be associated with adverse outcomes such as impaired access, prolonged operation time, the need to abort the operation, or the necessity for ancillary measures to achieve penile flaccidity, such as the injection of certain medications directly into the penis. To reduce greenhouse gas emissions, the primary use of propofol instead of gaseous agents is being recommended for general anesthesia. Whether propofol may be associated with an increased or decreased rate of unwanted intraoperative penile erection compared to other anesthetic agents is not known. More generally, there are no high-quality studies available to evaluate the impact of the type of general anesthesia on the risk of unwanted penile erections during surgery. This study aims to determine whether general anesthesia with propofol is more likely to cause intraoperative erections compared to sevoflurane during transurethral operations.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for phase_4

Timeline
6mo left

Started Feb 2024

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress80%
Feb 2024Dec 2026

Study Start

First participant enrolled

February 1, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 15, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 22, 2024

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

April 22, 2024

Status Verified

April 1, 2024

Enrollment Period

2.8 years

First QC Date

April 15, 2024

Last Update Submit

April 18, 2024

Conditions

Keywords

transurethral surgerypenile tumescenceintraoperative erectionpropofolsevofluraneinvestigator initiated trial

Outcome Measures

Primary Outcomes (1)

  • Intraoperative Penile Erection

    The primary endpoint "penile erection" will be analyzed as a binary outcome flaccid or erect. The occurrence of an erect penis at any time during surgery is classified as erect penile tumescence. Flaccid penile tumescence is classified only if erect penile tumescence does not occur at any point during the operation. The beginning and end of the operation are defined as the first insertion and last retrieval of all instruments, respectively. The penile tumescence will be reported in a simplified version of the validated EHS (erection hardness score): 0: flaccid, 1: increased tumescence, but not fully erect, 2: full erection. Erect penile tumescence is defined as achieving a score of either 1 or 2, whereas flaccid penile tumescence is defined as a score of 0.

    Assessment during the operation and reporting before the end of the surgery.

Secondary Outcomes (6)

  • Prolongation of the surgery

    Assessment during the operation and reporting before the end of the surgery.

  • Change in operative strategy

    Assessment during the operation and reporting before the end of the surgery.

  • Adaptions of instruments or approaches

    Assessment during the operation and reporting before the end of the surgery.

  • Altered operative outcome

    Assessment during the operation and reporting before the end of the surgery.

  • Necessity for a drug application to decrease penile tumescence

    Assessment during the operation and reporting before the end of the surgery.

  • +1 more secondary outcomes

Study Arms (2)

Intervention group: Propofol

ACTIVE COMPARATOR

The patients in the intervention group are receiving a general anesthesia with Propofol.

Drug: General Anesthesia: Propofol

Control group: Sevoflurane

ACTIVE COMPARATOR

The patients in the control group are receiving a general anesthesia with Sevoflurane.

Drug: General Anesthesia: Sevoflurane

Interventions

Transurethral surgery at the Department of Urology (University Hospital Zurich) performed under study arm-specific anesthesia. Propofol will be administered intravenously using the target-controlled infusion algorithm with effect site concentrations between 1.5-4.0 µg/ml necessary.

Intervention group: Propofol

Transurethral surgery at the Department of Urology (University Hospital Zurich) performed under study arm-specific anesthesia. Sevoflurane will be given in gaseous form via the endotracheal tube in concentrations between 1.5-2.5% Vol.

Control group: Sevoflurane

Eligibility Criteria

Age18 Years - 75 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Planned transurethral operation in the department of urology.
  • Preoperative IIEF-5 Score ≥12
  • Planned surgery time ≥15min

You may not qualify if:

  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant.
  • Inability to provide informed consent.
  • Contraindications to Propofol or Sevoflurane, e.g. known hypersensitivity or allergy.
  • Known or suspected non-compliance, drug or alcohol abuse.
  • Participation in another study with an investigational drug within the 30 days preceding and during the present study.
  • Previous enrolment into the current study.
  • Enrolment of the investigator, his/her family members, employees and other dependent persons.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Zurich

Zurich, 8091, Switzerland

RECRUITING

Related Publications (1)

  • Scherer TP, von Deschwanden C, Held U, Poyet C, Kwok JL, Kandler L, Schlapfer M, Keller EX, Schmid FA. Effect of Propofol Versus Sevoflurane on Erections during Narcosis in Transurethral Surgery: The PENIS Trial. Eur Urol Open Sci. 2024 Sep 24;69:100-104. doi: 10.1016/j.euros.2024.08.021. eCollection 2024 Nov.

Study Officials

  • Etienne X Keller, Ass Prof, MD

    University Hospital Zurich, University of Zurich

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Etienne X Keller, Ass Prof, MD

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The authorized study nurse will hand the upcoming envelope with the treatment allocation to the anesthesiologist. The patient and the urologists (who is measuring the outcome) will not know which form of general anesthesia will be performed. Herewith, blankets in the operating room will hide installations used by the anesthesiologists to prevent the urologists witnessing the assigned narcosis form. Before the surgical sign-out, while still scrubbed in and with the patient under anesthesia, the anesthesiologists will ask the urologists about the outcome questionnaire. Together, they will fill in the paper case report form (CRF).
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

April 15, 2024

First Posted

April 22, 2024

Study Start

February 1, 2024

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

April 22, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will share

After successful publishing, the data will be made available in anonymized form stored and in an open-access repository.

Shared Documents
STUDY PROTOCOL, ICF, ANALYTIC CODE
Time Frame
After successful publishing
Access Criteria
After successful publishing

Locations